These results clearly demonstrate that JNK activation-dependent FADD phosphorylation is an upstream signal to stabilise p53, and that JNK/FADD/p53 signals are essential for growth arrest by long-term tamoxifen treatment in human breast cancer cells. This evidence concerns the gene TP53 and breast cancer.